22 May 2013
Keywords: hemispherx, alferon, injection, top, anti-sars-cov, study, usa-based
Article | 26 April 2004
USA-based Hemispherx Biopharma has reported that results of an independent study, carried out by the Genome Institute of Singapore and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 April 2004
© 2013 thepharmaletter.com